tive individuals. Therefore, even though the duration of estrogen exposure was similar for subjects in this study, for those positive for ApoE4 the "critical period" may have already passed when they began therapy. In this situation, rather than excluding HRT as a potential method of preserving cognition in ApoE4 patients, they should be considered for earlier initiation of HRT.
Unfortunately, due to the Women's Health Initiative studies thus far published, this paper notwithstanding, it is unlikely that clinicians will recommend HRT as a means of preventing disease whether it be Alzheimer's disease, arterial disease, or even osteoporosis. Rather they will reserve HRT for those patients who need it to treat the unpleasant symptomatic effects of menopause. While this study may not have direct implications on current clinical practice, it may well provide clues into the mechanism by which ApoE4 confers an increased risk of AD. Stratifying the estrogen treated ApoE4 patients into quartiles (non-responders vs. responders) and looking for differences in estrogen receptor polymorphisms between these groups might be a first step. It is also important to keep in mind that the hypothalamic-pituitary-gonadal (HPG) axis is a complex endocrine feedback loop involving gonadotropin releasing hormone, leuteinizing hormone, follicle stimulating hormone, activin, inhibin, and follistatin, as well as the sex steroids. Just as with estrogen, the receptors for many of these hormones are expressed in multiple non-reproductive tissues. By definition, in any hormonal "feedback loop" altering the serum concentrations of any one hormone effects the serum concentrations of numerous others. Therefore, identifying the specific mechanism(s) by which a treatment such as HRT alters the clinical course of a disease becomes extremely complex. Effects seen with HRT may be due to the effect of estrogen not only on the serum concentrations of other hormones but also effects on expression levels of their receptors. Therefore, while it remains clear that the age-related changes in reproductive hormones play a role in numerous diseases of aging including AD, further research into the mechanism(s) by which this occurs should include a thorough study of all the hormones and receptors of the HPG axis.
